Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor N Rivas

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Scientific Reports|June 26, 2023
Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-CJoshua A Stern, Victor N Rivas, Joanna L Kaplan, et al.
Animals : an Open Access Journal From MDPI|October 28, 2023
Multi-Omic, Histopathologic, and Clinicopathologic Effects of Once-Weekly Oral Rapamycin in a Naturally Occurring Feline Model of Hypertrophic Cardiomyopathy: A Pilot StudyVictor N Rivas, Joanna L Kaplan, Susan A Kennedy, et al.
Circulation. Genomic and Precision Medicine|August 22, 2025
Novel <i>Cardiac Troponin-I</i> Missense Variant (c.593C>T) Is Associated With Familial Hypertrophic Cardiomyopathy in Golden RetrieversVictor N Rivas, Dayna A Goldsmith, Michael W Vandewege, et al.
Scientific Reports|January 2, 2023
Effects of Aficamten on cardiac contractility in a feline translational model of hypertrophic cardiomyopathyAshley N Sharpe, Maureen S Oldach, Victor N Rivas, et al.
Journal of the American Veterinary Medical Association|July 26, 2023
Delayed-release rapamycin halts progression of left ventricular hypertrophy in subclinical feline hypertrophic cardiomyopathy: results of the RAPACAT trialJoanna L Kaplan, Victor N Rivas, Ashley L Walker, et al.
Scientific Reports|May 27, 2024
Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathyVictor N Rivas, Amanda E Crofton, Carina E Jauregui, et al.
Plos Genetics|September 28, 2020
A nonsense variant in Rap Guanine Nucleotide Exchange Factor 5 (RAPGEF5) is associated with equine familial isolated hypoparathyroidism in Thoroughbred foalsVictor N Rivas, K Gary Magdesian, Sophia Fagan, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Scientific Reports|June 26, 2023
Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-CJoshua A Stern, Victor N Rivas, Joanna L Kaplan, et al.
Animals : an Open Access Journal From MDPI|October 28, 2023
Multi-Omic, Histopathologic, and Clinicopathologic Effects of Once-Weekly Oral Rapamycin in a Naturally Occurring Feline Model of Hypertrophic Cardiomyopathy: A Pilot StudyVictor N Rivas, Joanna L Kaplan, Susan A Kennedy, et al.
Circulation. Genomic and Precision Medicine|August 22, 2025
Novel <i>Cardiac Troponin-I</i> Missense Variant (c.593C>T) Is Associated With Familial Hypertrophic Cardiomyopathy in Golden RetrieversVictor N Rivas, Dayna A Goldsmith, Michael W Vandewege, et al.
Scientific Reports|January 2, 2023
Effects of Aficamten on cardiac contractility in a feline translational model of hypertrophic cardiomyopathyAshley N Sharpe, Maureen S Oldach, Victor N Rivas, et al.
Journal of the American Veterinary Medical Association|July 26, 2023
Delayed-release rapamycin halts progression of left ventricular hypertrophy in subclinical feline hypertrophic cardiomyopathy: results of the RAPACAT trialJoanna L Kaplan, Victor N Rivas, Ashley L Walker, et al.
Scientific Reports|May 27, 2024
Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathyVictor N Rivas, Amanda E Crofton, Carina E Jauregui, et al.
Plos Genetics|September 28, 2020
A nonsense variant in Rap Guanine Nucleotide Exchange Factor 5 (RAPGEF5) is associated with equine familial isolated hypoparathyroidism in Thoroughbred foalsVictor N Rivas, K Gary Magdesian, Sophia Fagan, et al.
Pageof 2